ShiChung Chang - Medigen Biotechnology Chairman Officer
| 3176 Stock | TWD 34.90 0.05 0.14% |
Insider
ShiChung Chang is Chairman Officer of Medigen Biotechnology
| Age | 64 |
| Phone | 886 2 7736 1234 |
| Web | https://www.medigen.com.tw |
Medigen Biotechnology Management Efficiency
Medigen Biotechnology's management efficiency ratios could be used to measure how well Medigen Biotechnology manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | INSIDER Age | ||
| Li Xie | Sinphar Pharmaceutical Co | N/A | |
| WeiKuo Hong | Chunghwa Telecom Co | 61 | |
| YiFen Huang | Zinwell | N/A | |
| RongShy Lin | Chunghwa Telecom Co | 56 | |
| LiangChang Chou | Kinko Optical Co | N/A | |
| James Chu | Apex Biotechnology Corp | N/A | |
| Xi Chen | E Lead Electronic Co | N/A | |
| Ying Zhu | Apex Biotechnology Corp | N/A | |
| ChingHui Lin | Zinwell | N/A | |
| Chun Wu | Apex Biotechnology Corp | N/A | |
| YuShen Chen | Chunghwa Telecom Co | 46 | |
| Zhen Wu | E Lead Electronic Co | N/A | |
| Feng Hong | Chunghwa Telecom Co | N/A | |
| YaChien Hsueh | Chunghwa Telecom Co | N/A | |
| WenShun Ho | Zinwell | N/A | |
| Thomas Shen | Apex Biotechnology Corp | N/A | |
| ChoFen Tsai | Chunghwa Telecom Co | N/A | |
| Ben Shen | Apex Biotechnology Corp | N/A | |
| Meng Yang | Apex Biotechnology Corp | N/A | |
| Mao Ke | E Lead Electronic Co | N/A | |
| ChingChi Chen | Kinko Optical Co | N/A | |
Management Performance
| Return On Equity | -0.0022 | |||
| Return On Asset | 0.0036 |
Medigen Biotechnology Leadership Team
Elected by the shareholders, the Medigen Biotechnology's board of directors comprises two types of representatives: Medigen Biotechnology inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Medigen. The board's role is to monitor Medigen Biotechnology's management team and ensure that shareholders' interests are well served. Medigen Biotechnology's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Medigen Biotechnology's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Bill Ou, CFO, Deputy General Manager | ||
| Wenlii Lin, Pres Bus | ||
| Eugene Cheng, General Manager, Director | ||
| ShiChung Chang, Chairman Officer |
Medigen Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Medigen Biotechnology a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.0022 | |||
| Return On Asset | 0.0036 | |||
| Profit Margin | (0.08) % | |||
| Operating Margin | 0.02 % | |||
| Current Valuation | 2.9 B | |||
| Shares Outstanding | 139.45 M | |||
| Shares Owned By Insiders | 25.17 % | |||
| Shares Owned By Institutions | 2.80 % | |||
| Price To Book | 2.01 X | |||
| Price To Sales | 1.66 X |
Pair Trading with Medigen Biotechnology
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Medigen Biotechnology position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Medigen Biotechnology will appreciate offsetting losses from the drop in the long position's value.Moving against Medigen Stock
The ability to find closely correlated positions to Medigen Biotechnology could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Medigen Biotechnology when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Medigen Biotechnology - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Medigen Biotechnology to buy it.
The correlation of Medigen Biotechnology is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Medigen Biotechnology moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Medigen Biotechnology moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Medigen Biotechnology can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Additional Tools for Medigen Stock Analysis
When running Medigen Biotechnology's price analysis, check to measure Medigen Biotechnology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Medigen Biotechnology is operating at the current time. Most of Medigen Biotechnology's value examination focuses on studying past and present price action to predict the probability of Medigen Biotechnology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Medigen Biotechnology's price. Additionally, you may evaluate how the addition of Medigen Biotechnology to your portfolios can decrease your overall portfolio volatility.